NEW YORK (GenomeWeb) – Illumina announced today that it has launched its noninvasive prenatal test, VeriSeq NIPT, as a CE-marked in vitro diagnostic in Europe. The test screens for trisomies 21, 18, and 13, as well as some sex chromosomal disorders at 10 weeks' gestation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.